台股 » 個股 » 佳醫 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

佳醫

(4104)
可現股當沖
  • 股價
    87.5
  • 漲跌
    ▼0.2
  • 漲幅
    -0.23%
  • 成交量
    66
  • 產業
    上市 生技醫療類股▼1.51%
  • 331人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
佳醫 (4104)籌碼相關-永豐金-中和 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-中和 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/0700.00187.6087.50-180-1.25%
2025/03/0500.00488.1388.00-479-5.03%
2025/02/24187.2000.0087.401741.35%
2025/02/21286.6000.0086.702722.76%
2025/02/06386.0000.0085.603763.94%
2025/01/220.186.2000.0085.900.1750.13%
2025/01/172.585.14185.0086.101.5761.90%
2025/01/1300.00484.5084.90-477-5.13%
2024/12/1300.000.287.2087.00-0.275-0.27%
2024/12/09187.5000.0087.601731.36%
2024/12/0200.001386.7186.60-1374-17.35%
2024/11/2900.00786.7786.70-774-9.41%
2024/11/2800.002.186.7586.70-2.174-2.75%
2024/11/27087.0000.0087.000740.02%
2024/11/15286.0000.0086.102852.33%
2024/10/1800.00788.0087.80-7114-6.12%
2024/10/0700.00287.6087.60-2118-1.68%
2024/09/25288.0000.0087.9021221.64%
2024/09/1300.00087.3087.200127-0.01%
2024/09/1100.00087.4086.800130-0.01%
2024/08/280.788.6000.0088.200.71350.55%
2024/08/2100.001092.0092.00-10139-7.15%
2024/08/162.191.7200.0092.302.11411.51%
2024/08/1511.191.2100.0092.3011.11407.90%
2024/08/1400.00190.7090.60-1135-0.74%
2024/08/13189.7000.0089.9011340.74%
2024/08/122.189.5100.0089.502.11371.54%
2024/08/090.187.8000.0087.500.11360.07%
2024/08/08187.3000.0087.4011370.73%
2024/08/070.887.6200.0087.100.81390.54%
2024/08/061.285.3200.0086.901.21400.86%
2024/08/050.186.5000.0086.100.11360.04%
2024/08/022.189.8800.0089.402.11301.63%
2024/08/01189.8000.0089.8011300.76%
2024/07/31188.6000.0088.9011310.76%
2024/07/300.188.6000.0088.800.11350.07%
2024/07/22288.1000.0088.1021401.43%
2024/07/19089.2000.0089.2001350.01%
2024/07/12189.3000.0089.3011640.61%
2024/07/111.189.3400.0089.301.11700.67%
2024/07/10289.4000.0089.5021781.12%
2024/07/08190.0000.0090.0011860.54%
2024/06/2500.00190.0090.00-1211-0.47%
2024/06/17190.3000.0090.4012280.44%
2024/06/130.190.0000.0089.700.12320.04%
2024/06/120.190.0000.0090.000.12380.04%
2024/06/0700.000.390.0589.90-0.3245-0.12%
2024/06/060.189.9000.0089.700.12520.05%
2024/06/040.189.6000.0089.400.12730.04%
2024/06/03189.3000.0089.2012760.36%
2024/05/23190.0000.0090.0013000.33%
2024/05/22190.7000.0090.5012970.34%
2024/05/16190.4000.0090.4013000.33%
2024/04/2500.00391.8091.80-3282-1.06%
2024/04/24192.10292.0092.10-1282-0.35%
2024/04/2200.00090.4090.5002820.00%
2024/04/19690.3000.0090.0062802.14%
2024/04/18194.5000.0094.6012660.38%
2024/04/17095.0000.0094.6002590.00%
2024/04/16193.6000.0094.0012540.39%
2024/04/120.196.5000.0096.300.12390.03%
2024/04/090.197.6000.0096.300.12260.04%
2024/04/08196.8000.0097.1012240.45%
2024/03/29196.1000.0096.2012170.46%
2024/03/2600.00194.8094.40-1207-0.48%
2024/03/2500.000.194.8094.80-0.1205-0.05%
2024/03/2200.000.694.3694.20-0.6204-0.30%
2024/03/211.193.8200.0094.301.12030.54%
2024/03/1500.00293.0093.80-2195-1.02%
2024/03/131.292.9900.0092.301.21950.59%
佳醫整併血液透析通路效益顯 下半年營運拚成長Anue鉅亨-2022/09/28
〈佳醫法說〉東南亞市場將調整產品結構 2-3年後可望發酵Anue鉅亨-2020/09/24
佳醫 相關文章
佳醫 相關影音